Michael Crescenzi
About Michael Crescenzi
Michael Crescenzi Biography
Michael Crescenzi holds the position of Vice President of Strategy & Business Development. With over 30 years of experience in the biopharma sector, he has gained expertise in strategy, business development, operations, and various commercial roles. His extensive professional background includes key positions in multiple notable companies within the industry.
Michael Crescenzi Education and Expertise
Michael Crescenzi earned a Bachelor of Science in Biology from Penn State University, providing him with a strong foundation in biological sciences. He furthered his education by obtaining an MBA from the University of Michigan, which equipped him with advanced knowledge in business administration and strategic management. This educational combination has contributed significantly to his proficiency in biopharma strategy and operations.
Michael Crescenzi Professional Background
Michael Crescenzi's professional background includes holding the role of Vice President of Strategy and Operations at Selenity Therapeutics. In addition, he served as Vice President of Commercial Operations at Viamet Pharmaceutics. His career also includes leading the Global IVIG franchise at Talecris Biotherapeutics, which later became part of Grifols. These roles have provided him with a broad range of experience in various facets of the biopharma industry.
Michael Crescenzi Career in Biopharma
Throughout his three-decade-long career in the biopharma industry, Michael Crescenzi has played pivotal roles in strategy, business development, and commercial operations. At Selenity Therapeutics, he contributed to strategic and operational functions as Vice President of Strategy and Operations. His tenure at Viamet Pharmaceutics as Vice President of Commercial Operations allowed him to focus on commercial aspects of the organization's operations. Additionally, his leadership of the Global IVIG franchise at Talecris Biotherapeutics/Grifols highlights his experience in global biopharma operations.